D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

MAZE holding history

Maze Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MAZE overview All 13F holders of MAZE Full Q2 2026 holdings

Shares (Q2 2026): 12,019
Value: $358.6K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of MAZE by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	12,019	$358.6K	<0.1%	−33,617−73.7%	Reduced	Holders
Q1 2026	45,636	$1.36M	<0.1%	+11,942+35.4%	Added	Holders
Q4 2025	33,694	$1.40M	<0.1%	+33,694	New	Holders